Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying
暂无分享,去创建一个
T. Rades | K. Löbmann | H. Grohganz | R. Laitinen | G. Craye
[1] P. Kleinebudde,et al. Preparation and characterization of spray‐dried co‐amorphous drug–amino acid salts , 2016, The Journal of pharmacy and pharmacology.
[2] Xing Tang,et al. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations , 2014, Drug delivery.
[3] T. Rades,et al. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media. , 2015, Die Pharmazie.
[4] G. Marosi,et al. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. , 2015, International journal of pharmaceutics.
[5] L. S. Taylor,et al. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles. , 2015, Molecular pharmaceutics.
[6] M. Videa,et al. Stabilization of amorphous paracetamol based systems using traditional and novel strategies. , 2014, International journal of pharmaceutics.
[7] Syed sajjad Hussen,et al. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] C. Strachan,et al. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability. , 2014, Molecular pharmaceutics.
[9] Lynne S Taylor,et al. Impact of surfactants on the crystal growth of amorphous celecoxib. , 2014, International journal of pharmaceutics.
[10] Yun Hu,et al. Mechanochemical Reaction of Sulfathiazole with Carboxylic Acids: Formation of a Cocrystal, a Salt, and Coamorphous Solids , 2014 .
[11] C. Strachan,et al. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures. , 2013, International journal of pharmaceutics.
[12] C. Strachan,et al. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] Beom-Jin Lee,et al. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] A. Jouyban,et al. Drug–Drug Coamorphous Systems: Characterization and Physicochemical Properties of Coamorphous Atorvastatin with Carvedilol and Glibenclamide , 2013, Journal of Pharmaceutical Innovation.
[15] R. O. Williams,et al. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. , 2013, International journal of pharmaceutics.
[16] Thomas Rades,et al. Emerging trends in the stabilization of amorphous drugs. , 2013, International journal of pharmaceutics.
[17] Jianjun Zhang,et al. Coamorphous repaglinide-saccharin with enhanced dissolution. , 2013, International journal of pharmaceutics.
[18] M. Tarnacka,et al. A new way of stabilization of furosemide upon cryogenic grinding by using acylated saccharides matrices. The role of hydrogen bonds in decomposition mechanism. , 2013, Molecular pharmaceutics.
[19] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[20] C. R. Rodrigues,et al. Efavirenz Dissolution Enhancement I: Co-Micronization , 2012, Pharmaceutics.
[21] Edward J. Donahue,et al. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin , 2012, Drug development and industrial pharmacy.
[22] R. Viana,et al. Infrared Spectroscopy of Anionic, Cationic, and Zwitterionic Surfactants , 2012 .
[23] C. Strachan,et al. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] K. Grzybowska,et al. Enhancement of amorphous celecoxib stability by mixing it with octaacetylmaltose: the molecular dynamics study. , 2012, Molecular pharmaceutics.
[25] Akash Jain,et al. Selection of oral bioavailability enhancing formulations during drug discovery , 2012, Drug development and industrial pharmacy.
[26] M. Brewster,et al. Supersaturating drug delivery systems: fast is not necessarily good enough. , 2012, Journal of pharmaceutical sciences.
[27] W. Qian,et al. Solid dispersions in the form of electrospun core-sheath nanofibers , 2011, International journal of nanomedicine.
[28] Wouter L J Hinrichs,et al. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations , 2011, Expert opinion on drug delivery.
[29] T. Ehtezazi,et al. The effect of spray drying on the compaction properties of hypromellose acetate succinate , 2011, Drug development and industrial pharmacy.
[30] M. Khan,et al. Influence of Formulation and Processing Factors on Stability of Levothyroxine Sodium Pentahydrate , 2010, AAPS PharmSciTech.
[31] O. Abdel-Kareem,et al. Morphological, Rheological and Ultrasonic Characterizations of ECO- Friendly Microemulsion Lattices Based on Acrylate Monomers. , 2010 .
[32] G. Van den Mooter,et al. Review: physical chemistry of solid dispersions. , 2009, The Journal of pharmacy and pharmacology.
[33] S. Bhise,et al. Formulation and Evaluation of Novel FDCs of Antitubercular Drugs , 2009 .
[34] G. Gupta,et al. A Discriminatory and Biorelevant Dissolution Test Method for Simvastatin Drug Products , 2009 .
[35] Patrick J. Marsac,et al. Estimation of Drug–Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters , 2008, Pharmaceutical Research.
[36] Patrick J. Marsac,et al. A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems , 2006, Pharmaceutical Research.
[37] P. Sinko. Martin's Physical Pharmacy and Pharmaceutical Sciences , 2005 .
[38] K. Mahadik,et al. Spray-Dried Amorphous Solid Dispersions of Simvastatin, a Low Tg Drug: In Vitro and in Vivo Evaluations , 2005, Pharmaceutical Research.
[39] Y. Kawashima,et al. Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method , 2004 .
[40] F. Sadeghi,et al. Increasing the Aqueous Solubility of Acetaminophen in the Presence of Polyvinylpyrrolidone and Investigation of the Mechanisms Involved , 2003, Drug development and industrial pharmacy.
[41] E. Franses,et al. Infrared reflection absorption spectroscopy (IRRAS) of aqueous nonsurfactant salts, ionic surfactants, and mixed ionic surfactants , 2002 .
[42] D. Shah,et al. On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants , 2000 .
[43] M. Malmsten,et al. Spray-drying of trypsin - surface characterisation and activity preservation. , 1999, International journal of pharmaceutics.
[44] G. Winter,et al. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems. , 1999, Pharmaceutical development and technology.
[45] T. Kawai,et al. Fourier Transform Infrared Study on the Phase Transitions of a Sodium Dodecyl Sulfate-Water System , 1983 .
[46] D. E. Cadwallader,et al. Effect of macromolecules on aqueous solubility of cholesterol and hormone drugs. , 1981, Journal of pharmaceutical sciences.